>>Signaling Pathways>> Others>>FPR Agonist 43

FPR Agonist 43 (Synonyms: FPR Agonist 43)

Catalog No.GC36075

FPR 작용제 43(화합물 43)은 이중 포르밀 펩티드 수용체 1(FPR1) 및 포르밀 펩티드 수용체 2(FPR2)/ALX 작용제입니다.

Products are for research use only. Not for human use. We do not sell to patients.

FPR Agonist 43 Chemical Structure

Cas No.: 903895-98-7

Size 가격 재고 수량
10mM (in 1mL DMSO)
US$188.00
재고 있음
5mg
US$171.00
재고 있음
10mg
US$261.00
재고 있음
25mg
US$513.00
재고 있음
50mg
US$819.00
재고 있음
100mg
US$1,305.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

FPR Agonist 43 (compound 43) is a dual formyl peptide receptor 1 (FPR1) and formyl peptide receptor 2 (FPR2)/ALX agonist[1][2]. FPR1, FPR2/ALX[1]

FPR Agonist 43 (10-5-107 nM) is actively potent in the cAMP assay in FPR2/ALX over-expressing CHO cells[1]. FPR Agonist 43 is also active in the GTPγ binding assay (IC50=207±51 nM)[1].FPR1 is the preferred receptor for FPR Agonist 43 in in both human neutrophils and possibly also in mouse cells[2]. Cell Viability Assay[1] Cell Line: Chinese hamster ovary (CHO) over-expressing human FPR2/ALX receptors

[1]. PlanagumÀ A, et al. Lack of activity of 15-epi-lipoxin A? on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function. Clin Exp Immunol. 2013 Aug;173(2):298-309. [2]. Forsman H, et al. What formyl peptide receptors, if any, are triggered by compound 43 and lipoxin A4• Scand J Immunol. 2011 Sep;74(3):227-234.

리뷰

Review for FPR Agonist 43

Average Rating: 5 ★★★★★ (Based on Reviews and 34 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for FPR Agonist 43

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.